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Background. In rats, protein-restricted diets prolong survival
from experimental chronic kidney disease (CKD). Diets for
CKD patients that are restricted in protein and modified to
limit the intake of phosphates and sodium not only reduce the
accumulation of unexcreted metabolic products but also pro-
tect against hypertension and proteinuria. Their ability to slow
progression of CKD is controversial, and this fact, plus concern
about the nutritional adequacy of restricted diets, has limited
this treatment strategy for CKD patients.
Methods. Expected responses of CKD patients to dietary ma-
nipulation are examined. The influence of this strategy on com-
plications of CKD, including results from the MDRD Study, is
analyzed.
Results. Dietary compliance with low-protein diets can be
monitored from 24-hour urea excretion. Long-term therapy
with diets containing 0.6 g protein/kg/day or less protein sup-
plemented with essential amino acids or their ketoanalogues
maintain body weight and normal values of serum proteins
while reducing the accumulation of acid, phosphates, urea.
Low-protein diets suppress proteinuria even when angiotensin-
converting enzyme inhibitors are used. Patients in the MDRD
Study who complied with the diet had a significant slowing of
the rate of loss of glomerular filtration rate (GFR).
Conclusion. Successful dietary manipulation can ameliorate
many complications of CKD. Low-protein diets are nutrition-
ally safe, they reduce the accumulation of metabolic products,
and they can suppress progressive loss of kidney function. Di-
etary manipulation should be an integral part of the therapy for
patients with progressive CKD.
Progressive cardiovascular disease has been added to
the long list of problems caused by chronic kidney dis-
ease (CKD) [1]. Proposed mechanisms of atherosclerosis
include hypertension, an abnormal lipid profile, inflam-
mation, urate accumulation, and the “uremic state” [1,
2]. Recently, a close link between cardiovascular disease
and albuminuria has been established in CKD [3]. How
does the diet affect these mechanisms? Hypertension in
CKD is almost certainly related to impaired ability of the
kidney to regulate salt balance, while inflammation and
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the influence of urate are related to high-protein diets [2,
4, 5]. In short, these problems, like other CKD-associated
problems (accumulation of uremic toxins arising from
protein metabolism, accumulation of phosphates, acids
that cause abnormal bone and muscle metabolism, and
anemia, etc.) can be ameliorated by careful planning of a
low-protein diet. This is not a new concept: in 1869, Beale
wrote that a protein-restricted diet will ameliorate uremic
symptoms [6]. Recent publications confirm these benefits
[7]. The basis for improvements in uremic symptoms and
complications of CKD, such as hyperparathyroidism, ab-
normal glucose metabolism, metabolic responses to aci-
dosis, as well as hypertension, is that a low-protein diet
also will limit the intake of phosphates, acid, and salt, as
well as precursors of uremic toxins [8].
Why then is dietary counseling not provided regularly
for CKD patients? One reason is that physicians are not
trained to provide dietary analysis and planning so they
rarely attempt to offer dietary counseling. In the United
States, these difficulties are largely eliminated as Medi-
care pays for dietary counseling. Two other reasons why
CKD patients are not given dietary instruction are a con-
cern that CKD patients will develop “malnutrition,” and
the disappointing results from the Modification of Diet
in Renal Disease (MDRD) Study [9, 10]. Fortunately,
there is abundant evidence that treatment of CKD pa-
tients with low-protein diets exerts beneficial responses
with minimal risk of a poor nutritional outcome [11].
DO LOW-PROTEIN DIETS CAUSE
MALNUTRITION?
Reports that dialysis patients lose weight and can have
low serum albumin levels has led to concern that low-
protein diets prescribed before beginning dialysis therapy
cause malnutrition [9]. In large part, the proscription of
low-protein diets arose from the conclusion that hypoal-
buminemia and excessive mortality in hemodialysis pa-
tients is due to malnutrition [9]. This is incorrect. CKD
leads to several mechanisms that lower serum albumin
and cause loss of lean body mass, and these do not in-
clude malnutrition [12]. In fact, malnutrition refers to
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abnormalities caused by an inadequate amount of nu-
trients in the diet, or by an unbalanced diet, and careful
examination shows that the major factor associated with
hypoalbuminemia in hemodialysis patients is evidence of
inflammation; the diet plays a minor role [13]. More im-
portantly, the MDRD Study revealed that CKD patients
treated with low-protein diets had a small but statistically
significant increase in serum albumin [14]. Other investi-
gators studying smaller groups of patients have found that
long-term treatment with a low-protein diet is associated
with higher serum protein concentrations at the initiation
of dialysis therapy [15]. The complications of CKD that
can cause hypoalbuminemia and loss of lean body mass
include metabolic acidosis, insulin resistance, the dialysis
procedure itself, as well as inflammation [12]. CKD pa-
tients who were treated with a low-protein diet for pro-
longed periods exhibit improved survival after they begin
dialysis [16, 17].
Traditional methods of assessing the nutritional ade-
quacy of low-protein diets include measurements of ni-
trogen balance and serum proteins plus estimates of the
changes in lean body mass. In patients with uncompli-
cated CKD (i.e., no catabolic illness or metabolic acido-
sis), diets with the minimum daily requirement for protein
(0.6 g protein/kg ideal body weight/day), or a very-low-
protein diet (VLPD) containing ∼0.3 g protein/kg/day
of predominantly vegetable protein supplemented with
a mixture of essential amino acids (EAA) and their
nitrogen-free analogues (ketoacids) produce neutral ni-
trogen balance and maintain normal serum protein levels
and lean body mass [18–20]. These diets are also safe dur-
ing long-term therapy: only 2 patients withdrew from the
MDRD Study because of impaired nutritional status [14].
MONITORING DIETARY ADEQUACY
AND COMPLIANCE
Nutritional therapy requires regular assessment of di-
etary compliance and protein stores. Fortunately, the
amount of protein eaten by CKD patients can be accu-
rately estimated [21, 22]. Measuring daily urea nitrogen
production is the key to the method because protein ni-
trogen in the diet, or arising from turnover of body pro-
teins, is converted almost entirely to urea nitrogen. In
contrast, the nitrogen excreted as creatinine, uric acid,
ammonia, peptides, and in feces (excretion of nonurea ni-
trogen) does not vary with dietary protein, and averages
0.031 g nitrogen/kilogram ideal body weight/day [21]. To
monitor how well a CKD patient is complying with the
amount of dietary protein prescribed, a 24-hour urine is
collected to measure daily urea nitrogen excretion. This
value is added to the nonurea nitrogen excretion (0.031 ×
body weight) to calculate total nitrogen excretion. In the
steady state when weight and SUN are stable, nitrogen
excretion equals nitrogen intake. Once nitrogen intake is
calculated, it is converted to protein intake by multiplying
by 6.25 g protein/g nitrogen. If the patient is eating more
(or less) than the prescribed amount, a meeting with the
dietician should be scheduled.
Estimating changes in protein stores is not as simple,
and requires serial measurements of anthropometrics,
serum albumin, and transferring, while understanding
a patient’s activity (so that calorie intake can be ad-
justed accordingly). A nutritionist can monitor these in-
dices while providing skilled advice to the patient about
changes in the diet [23].
EXPECTED RESPONSES TO DIETARY
MANIPULATION
The metabolism of protein stores yields a large num-
ber of products that are listed as causes of the uremic
syndrome [8]. Since urea is the major end product of pro-
tein metabolism, when the blood urea nitrogen falls be-
cause dietary protein is restricted, accumulation of other
nitrogen-containing compounds will also decrease [7, 8,
17]. In addition, foods rich in protein will also contain ex-
cessive amounts of salt, phosphates, other ions, and fixed
acid so low-protein diets will limit the tendency for hy-
pertension, hyperphosphatemia, and metabolic acidosis
[11, 17].
DIETARY PROTEIN RESTRICTION AND
PROGRESSION OF RENAL INSUFFICIENCY
Reports written more than 65 years ago showed that
dietary protein restriction slows kidney damage in rat
models of CKD [23]. In CKD patients with different
causes of CKD, including diabetes, low-protein diets also
slow the loss of renal function [8, 23]. Recent reports
confirm this beneficial response to low-protein diets, es-
pecially when patients are treated with a ketoacid supple-
ment [24]. On the other hand, results from the MDRD
Study led to the conclusion that there was no signif-
icant benefit of low-protein diets, including diets sup-
plemented with ketoacids [10]. Problems with accepting
this conclusion have been detailed [8, 23]: the principal
problems are that the responses were calculated accord-
ing to the prescribed diet, and not whether the patient
actually restricted his/her dietary protein. In addition,
there was no control group eating unrestricted diets in
the study of patients with advanced renal insufficiency
(<25 mL/min/1.73m2). Notably, when progression was as-
sessed according to the actual amount of dietary protein,
there was significant slowing of the loss of GFR for pa-
tients who complied with the low-protein diets [25].
How a low-protein diet could slow the loss of kid-
ney function is unclear, even in animal studies. One
possibility is linked to the fact that dietary protein re-
striction reduces proteinuria, even when it is given with
Mitch: Nutritional therapy for chronic kidney disease S-135
angiotensin-converting enzyme inhibitors [26, 27]. This
is relevant because a decrease in proteinuria in patients
with type 2 diabetes is highly associated with slowing of
the loss of kidney function [28].
CONCLUSION
A low-protein diet is nutritionally sound for CKD pa-
tients as long as there is no complicating disease, and dur-
ing long-term therapy, their use will lead to improvements
in uremic symptoms and blood chemistries. It is still unset-
tled whether these diets will slow the loss of residual renal
function. The beneficial responses for proteinuria, insulin
resistence, the development of hyperparathyroidism or
metabolic acidosis, and uremic symptoms indicate that
dietary counseling should be an integral part of the ther-
apy of CKD [11].
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